AGNG


Aging Population ETF

Morningstar Rating™ - Overall rating out of 165 Health funds, based on risk-adjusted returns as of 01/31/2025

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults 65 and older could double to 1.7B by 2053.1

Unique Care Needs Driving Demand

Older individuals, those 65 and older, make up 17% of the U.S. population and account for 37% of healthcare spending.2,3 Nearly 70% of adults 65 and older will require long-term care in their lifetime.4

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

1United Nations, Jul 2024
2Ibid
3Centers for Medicare & Medicaid Services, Sep 2024
4U.S. Department of Health and Human Services, Office of Disability Aging and Long-Term Care Policy, and Urban Institute, Apr 2019

Key Information As of 03/14/25

Inception Date 05/09/16
Total Expense Ratio 0.50%
Net Assets $60.07 million
NAV $31.45
Fact Sheet View the document

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 03/13/25

Ticker AGNG
Bloomberg Index Ticker ILNGRNT
CUSIP 37954Y772
ISIN US37954Y7720
Primary Exchange Nasdaq
Shares Outstanding 1,910,000
Number of Holdings 83
30-Day Median Bid-Ask Spread 0.34%

Distributions As of 03/14/25

30-Day SEC Yield 0.99%
Distribution Frequency Semi-Annually

ETF Prices As of 03/14/25

NAV $31.45 Daily Change $0.29 0.93%
Market Price $31.48 Daily Change $0.42 1.35%

Performance History

As of recent
(12/31/24)
As of recent
(12/31/24)
Fund NAV Market Price Index
1 Year 6.81% 7.04% 7.21%
3 Years 2.34% 2.36% 2.65%
5 Years 5.79% 5.80% 6.07%
Since Inception 9.08% 9.34% 9.39%
1 Year 11.58% 10.37% 12.07%
3 Years 6.87% 6.88% 7.18%
5 Years 8.37% 8.12% 8.65%
Since Inception 9.74% 10.00% 10.04%
Year-to-Date 6.81% 7.04% 7.21%
1 Month -4.90% -5.05% -4.86%
3 Months -7.34% -7.59% -7.21%
Since Inception 112.18% 116.59% 117.32%
Year-to-Date 6.95% 6.92% 6.97%
1 Month 1.51% 2.15% 1.50%
3 Months 1.71% 1.52% 1.78%
Since Inception 126.94% 131.58% 132.47%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 03/14/25

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
4.58 WELL WELLTOWER INC BYVYHH4 147.84 18,625 2,753,520.00
3.96 BSX BOSTON SCIENTIFIC CORP 2113434 97.16 24,450 2,375,562.00
3.80 4519 JP CHUGAI PHARMA CO 6196408 46.33 49,275 2,283,010.30
3.54 ABBV ABBVIE INC B92SR70 211.77 10,048 2,127,864.96
3.37 BMY BRISTOL-MYERS SQUIBB CO 2126335 59.01 34,266 2,022,036.66
3.29 RO SW ROCHE HOLDING AG-BR 7108918 365.67 5,400 1,974,613.21
3.26 AMGN AMGEN INC 2023607 313.71 6,234 1,955,668.14
3.22 UCB BB UCB SA 5596991 195.54 9,878 1,931,566.51
3.16 MDT MEDTRONIC PLC BTN1Y11 93.07 20,412 1,899,744.84
3.12 AZN ASTRAZENECA PLC-SPONS ADR 2989044 77.60 24,151 1,874,117.60
3.06 JNJ JOHNSON & JOHNSON 2475833 162.81 11,273 1,835,357.13
3.01 ALC SW ALCON INC BJT1GR5 88.36 20,430 1,805,130.66
2.99 LLY ELI LILLY & CO 2516152 813.48 2,208 1,796,163.84
2.98 SYK STRYKER CORP 2853688 369.53 4,844 1,790,003.32
2.46 068270 KS CELLTRION INC B0C5YV1 128.02 11,554 1,479,057.82
2.34 4543 JP TERUMO CORP 6885074 18.56 75,699 1,405,259.69
2.27 VTR VENTAS INC 2927925 66.89 20,387 1,363,686.43
2.12 EW EDWARDS LIFESCIENCES CORP 2567116 69.29 18,347 1,271,263.63
2.09 ONC BEIGENE LTD-ADR BYYWPW6 259.19 4,843 1,255,257.17
2.02 REGN REGENERON PHARMACEUTICALS 2730190 666.87 1,822 1,215,037.14
1.90 ZBH ZIMMER BIOMET HO 2783815 109.97 10,388 1,142,368.36
1.74 STMN SW STRAUMANN HOLDING AG-REG BQ7ZV06 129.14 8,068 1,041,869.90
1.73 NOVOB DC NOVO NORDISK A/S-B BP6KMJ1 77.26 13,440 1,038,418.59
1.52 SDZ SW SANDOZ GROUP AG BLPLD38 41.85 21,826 913,463.08
1.52 SOON SW SONOVA HOLDING AG-REG 7156036 301.86 3,017 910,721.74
1.51 4503 JP ASTELLAS PHARMA INC 6985383 9.88 91,841 907,804.52
1.51 PODD INSULET CORP B1XGNW4 255.44 3,546 905,790.24
1.41 DXCM DEXCOM INC B0796X4 70.69 12,008 848,845.52
1.28 INCY INCYTE CORP 2471950 67.86 11,368 771,432.48
1.22 UTHR UNITED THERAPEUTICS CORP 2430412 307.24 2,383 732,152.92
1.22 3692 HK HANSOH PHARMACEU BJYKB72 2.44 299,843 731,456.12
1.19 FME GR FRESENIUS MEDICAL CARE AG 5129074 47.89 14,924 714,761.84
1.15 GMAB DC GENMAB A/S 4595739 206.05 3,354 691,108.02
1.06 DVA DAVITA INC 2898087 143.45 4,440 636,918.00
1.05 SN/ LN SMITH & NEPHEW PLC 0922320 14.13 44,472 628,372.48
0.94 EXEL EXELIXIS INC 2576941 36.65 15,340 562,211.00
0.93 NBIX NEUROCRINE BIOSC 2623911 110.75 5,037 557,847.75
0.92 PHM SM PHARMA MAR SA BMW2GT8 97.58 5,656 551,917.37
0.92 COH AU COCHLEAR LTD 6211798 165.68 3,318 549,733.76
0.78 OHI OMEGA HEALTHCARE 2043274 37.62 12,409 466,826.58
0.69 EXAS EXACT SCIENCES CORP 2719951 45.00 9,185 413,325.00
0.69 DEMANT DC DEMANT A/S BZ01RF1 36.31 11,356 412,388.82
0.67 HALO HALOZYME THERAPEUTICS INC 2975098 62.27 6,433 400,582.91
0.60 ENSG ENSIGN GROUP INC/THE B1YWPP8 125.40 2,867 359,521.80
0.55 TFX TELEFLEX INC 2881407 137.71 2,387 328,713.77
0.48 MMSI MERIT MEDICAL SYSTEMS INC 2580555 98.94 2,936 290,487.84
0.46 BPMC BLUEPRINT MEDICINES CORP BWY52P3 89.58 3,101 277,787.58
0.43 YPSN SW YPSOMED HOLDING AG-REG B02SWN8 373.80 691 258,295.88
0.43 GKOS GLAUKOS CORP BYMWL19 102.19 2,504 255,883.76
0.42 AMP IM AMPLIFON SPA B14NJ71 21.72 11,480 249,321.01
0.40 853 HK MICROPORT SCIENTIFIC CORP B676TW7 1.12 216,302 242,957.78
0.39 NVCR NOVOCURE LTD BYSS4X4 19.49 11,862 231,190.38
0.36 NHI NATL HEALTH INVESTORS INC 2626125 75.10 2,844 213,584.40
0.35 SBRA SABRA HEALTH CAR B5NLBP6 17.30 12,152 210,229.60
0.35 CSH-U CN CHARTWELL RETIRE B8S8C94 11.49 18,273 210,043.25
0.34 MNKD MANNKIND CORP BF081J4 5.20 38,960 202,592.00
0.33 EMBC EMBECTA CORP BMXWYR1 13.15 15,216 200,090.40
0.33 ITGR INTEGER HOLDINGS CORP BD06LM7 117.89 1,694 199,705.66
0.31 SIA CN SIENNA SENIOR LIVING INC BWTYXH4 10.89 17,266 188,022.36
0.31 LTC LTC PROPERTIES INC 2498788 35.96 5,206 187,207.76
0.31 8086 JP NIPRO CORP 6641599 9.08 20,328 184,507.59
0.30 AED BB AEDIFICA B1G5XP1 67.30 2,689 180,972.11
0.29 NHC NATIONAL HEALTHCARE CORP 2139731 93.62 1,865 174,601.30
0.29 TBPH THERAVANCE BIOPHARMA INC BMNDK09 9.23 18,741 172,979.43
0.28 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 30.93 5,472 169,248.96
0.28 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 0.69 244,489 168,608.76
0.28 ACAD ACADIA PHARMACEU 2713317 17.50 9,623 168,402.50
0.28 AMED AMEDISYS INC 2024332 92.57 1,814 167,921.98
0.26 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.21 734,692 155,026.23
0.25 BKD BROOKDALE SR B0PZN33 6.08 25,134 152,814.72
0.24 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.31 465,424 142,521.95
0.23 RYM NZ RYMAN HEALTHCARE LTD 6161525 1.67 83,132 138,870.68
0.22 DNLI DENALI THERAPEUTICS INC BD2B4V0 15.15 8,742 132,441.30
0.22 GN DC GN STORE NORD A/S 4501093 17.14 7,651 131,172.74
0.22 EKTAB SS ELEKTA AB-B SHS B0M42T2 5.64 22,913 129,284.70
0.21 AGL AGILON HEALTH INC BLR4TK4 4.05 31,426 127,275.30
0.20 LIVN LIVANOVA PLC BYMT0J1 39.24 3,096 121,487.04
0.19 OTHER PAYABLE & RECEIVABLES 1.00 112,937 112,936.84
0.19 ATEC ALPHATEC HOLDINGS INC BD60BG7 9.29 11,947 110,987.63
0.13 145720 KS DENTIUM CO LTD BF07GJ6 42.72 1,774 75,782.76
0.07 9229 JP SUNWELS CO LTD BNTYNB5 4.07 10,514 42,759.69
0.07 ALEC ALECTOR INC BJ4LDC4 1.45 26,820 38,889.00
0.04 2500 HK VENUS MEDTECH -H BL6V047 0.23 102,940 23,443.01
0.00 RADIUS HEALTH INC - CVR 2KFF9T0 0.00 19,104 0.02
0.00 CANADIAN DOLLAR 0.70 -135 -93.65
0.00 DANISH KRONE 0.15 -997 -145.35
-0.01 CASH 1.00 -6,520 -6,519.50
Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 02/28/25

Sector Weight (%)
Health Care 91.1
Real Estate 8.9

Source: new windowAltaVista Research, LLC

Industry Weight (%)
Pharmaceuticals, Biotechnology & Life Sciences 47.7
Health Care Equipment & Services 38.9
Equity Real Estate Investment Trusts (REITs) 8.9
Pharmaceuticals, Biotechnology 4.5

Source: new windowAltaVista Research, LLC

Country Weight (%)
United States 53.8
Switzerland 11.5
Japan 8.0
Britain 4.6
China 4.4
Denmark 4.1
Belgium 3.3
Ireland 3.1
South Korea 2.5
Germany 1.2
Spain 0.9
Other 2.6

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 03/14/25

Return on Equity 16.00%
Weighted Avg. Market Cap 110,891 M
2024 2025
Price-to-earnings 25.88 20.63
Price-to-book value 3.49 3.15

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 02/28/25

Versus Beta
S&P 500 0.70
NASDAQ-100 0.47
MSCI EAFE 0.74
MSCI Emg. Mkts 0.50
Standard Deviation 15.00%

Source: new windowAltaVista Research, LLC

ETF Research

The Morningstar Rating™ for funds, or “star rating”, is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product’s monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The Morningstar Rating does not include any adjustment for sales load. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three- year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods.

As of 1/31, AGNG was rated against the following numbers of Health funds over the following time periods: 165 during the last 3 years, 149 during the last 5 years. With respect to these Technology funds, AGNG received a Morningstar Rating of 5, and 3 stars, respectively. Past performance is not indicative of future results.

© 2025 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.